GUY, D.; GLICKSMAN, R.; BUCKLEY, R.; CHEUNG, P.; CHUNG, H.; FLAX, S.; HAJEK, D.; LOBLAW, A.; MORTON, G.; NOAKES, J.; SPEVACK, L.; CHIN, J. L. .; RODRIGUES, G. Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. Canadian Urological Association Journal, [S. l.], v. 16, n. 4, p. E220–6, 2021. DOI: 10.5489/cuaj.7525. Disponível em: https://cuaj.ca/index.php/journal/article/view/7525. Acesso em: 24 apr. 2024.